Aims. Although adequate clinical management of patients with hypercholesterolemia without
a history of known cardiovascular disease is essential for prevention, these subjects are …

Atherosclerosis is a chronic process characterized by inflammation and the progressive
accumulation of inflammatory cells and lipids in the blood vessel wall, resulting in narrowing …

Background Young adults may have high long-term atherosclerotic cardiovascular disease
(ASCVD) risk despite low short-term risk. Objectives In this study, we sought to compare the …

HMG-CoA reductase inhibitors (statins) are widely used in the therapy of atherosclerosis
and have a number of pleiotropic effects, including DNA repair regulation. We studied the …

Aim: To determine the complementary effects of dabigatran etexilate (DE), exercise training
(ET), and combination (DE+ ET) on the development and stability of the atherosclerotic …

Cardiovascular disease (CVD) is one of the main causes of death in the world. The
increased level of blood cholesterol is significantly correlated to CVD incidents. Statins are a …

Purpose There are few studies in the literature on the dosage of statin that equivalently
reduces low-density lipoprotein cholesterol (LDL-C) compared to an ezetimibe combination …

Abstract Purpose of Review Statins inhibit the enzyme 3-hydroxy-3-methylglutaryl-coenzyme
A reductase in the liver and reduce atherosclerotic cardiovascular disease (ASCVD) risk by …

The effectiveness of lipid-lowering therapies may be insufficient in high-risk cardiovascular
patients and depends on the genetic variability of drug-metabolizing enzymes. Customizing …

Rationale: Obstructive sleep apnea (OSA) is an independent risk factor for cardiovascular
(CV) morbidity and mortality, but the benefit of continuous positive airway pressure (CPAP) …